1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Gynecology Drugs Revenue 1.4 Market Analysis by Type 1.4.1 Global Gynecology Drugs Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Hormonal Therapy 1.4.3 Non-hormonal Therapy 1.5 Market by Application 1.5.1 Global Gynecology Drugs Market Share by Application: 2020 VS 2026 1.5.2 Hospital Pharmacies 1.5.3 Retail Pharmacies 1.5.4 Online Pharmacies 1.6 Coronavirus Disease 2019 (Covid-19): Gynecology Drugs Industry Impact 1.6.1 How the Covid-19 is Affecting the Gynecology Drugs Industry 1.6.1.1 Gynecology Drugs Business Impact Assessment - Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Gynecology Drugs Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for Gynecology Drugs Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Global Growth Trends by Regions 2.1 Gynecology Drugs Market Perspective (2015-2026) 2.2 Gynecology Drugs Growth Trends by Regions 2.2.1 Gynecology Drugs Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Gynecology Drugs Historic Market Share by Regions (2015-2020) 2.2.3 Gynecology Drugs Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Gynecology Drugs Market Growth Strategy 2.3.6 Primary Interviews with Key Gynecology Drugs Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Gynecology Drugs Players by Market Size 3.1.1 Global Top Gynecology Drugs Players by Revenue (2015-2020) 3.1.2 Global Gynecology Drugs Revenue Market Share by Players (2015-2020) 3.1.3 Global Gynecology Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Gynecology Drugs Market Concentration Ratio 3.2.1 Global Gynecology Drugs Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Gynecology Drugs Revenue in 2019 3.3 Gynecology Drugs Key Players Head office and Area Served 3.4 Key Players Gynecology Drugs Product Solution and Service 3.5 Date of Enter into Gynecology Drugs Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Gynecology Drugs Historic Market Size by Type (2015-2020) 4.2 Global Gynecology Drugs Forecasted Market Size by Type (2021-2026) 5 Gynecology Drugs Breakdown Data by Application (2015-2026) 5.1 Global Gynecology Drugs Market Size by Application (2015-2020) 5.2 Global Gynecology Drugs Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Gynecology Drugs Market Size (2015-2020) 6.2 Gynecology Drugs Key Players in North America (2019-2020) 6.3 North America Gynecology Drugs Market Size by Type (2015-2020) 6.4 North America Gynecology Drugs Market Size by Application (2015-2020) 7 Europe 7.1 Europe Gynecology Drugs Market Size (2015-2020) 7.2 Gynecology Drugs Key Players in Europe (2019-2020) 7.3 Europe Gynecology Drugs Market Size by Type (2015-2020) 7.4 Europe Gynecology Drugs Market Size by Application (2015-2020) 8 China 8.1 China Gynecology Drugs Market Size (2015-2020) 8.2 Gynecology Drugs Key Players in China (2019-2020) 8.3 China Gynecology Drugs Market Size by Type (2015-2020) 8.4 China Gynecology Drugs Market Size by Application (2015-2020) 9 Japan 9.1 Japan Gynecology Drugs Market Size (2015-2020) 9.2 Gynecology Drugs Key Players in Japan (2019-2020) 9.3 Japan Gynecology Drugs Market Size by Type (2015-2020) 9.4 Japan Gynecology Drugs Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Gynecology Drugs Market Size (2015-2020) 10.2 Gynecology Drugs Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Gynecology Drugs Market Size by Type (2015-2020) 10.4 Southeast Asia Gynecology Drugs Market Size by Application (2015-2020) 11 India 11.1 India Gynecology Drugs Market Size (2015-2020) 11.2 Gynecology Drugs Key Players in India (2019-2020) 11.3 India Gynecology Drugs Market Size by Type (2015-2020) 11.4 India Gynecology Drugs Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Gynecology Drugs Market Size (2015-2020) 12.2 Gynecology Drugs Key Players in Central & South America (2019-2020) 12.3 Central & South America Gynecology Drugs Market Size by Type (2015-2020) 12.4 Central & South America Gynecology Drugs Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 Pfizer 13.1.1 Pfizer Company Details 13.1.2 Pfizer Business Overview and Its Total Revenue 13.1.3 Pfizer Gynecology Drugs Introduction 13.1.4 Pfizer Revenue in Gynecology Drugs Business (2015-2020)) 13.1.5 Pfizer Recent Development 13.2 Roche 13.2.1 Roche Company Details 13.2.2 Roche Business Overview and Its Total Revenue 13.2.3 Roche Gynecology Drugs Introduction 13.2.4 Roche Revenue in Gynecology Drugs Business (2015-2020) 13.2.5 Roche Recent Development 13.3 AbbVie 13.3.1 AbbVie Company Details 13.3.2 AbbVie Business Overview and Its Total Revenue 13.3.3 AbbVie Gynecology Drugs Introduction 13.3.4 AbbVie Revenue in Gynecology Drugs Business (2015-2020) 13.3.5 AbbVie Recent Development 13.4 Bayer 13.4.1 Bayer Company Details 13.4.2 Bayer Business Overview and Its Total Revenue 13.4.3 Bayer Gynecology Drugs Introduction 13.4.4 Bayer Revenue in Gynecology Drugs Business (2015-2020) 13.4.5 Bayer Recent Development 13.5 Merck 13.5.1 Merck Company Details 13.5.2 Merck Business Overview and Its Total Revenue 13.5.3 Merck Gynecology Drugs Introduction 13.5.4 Merck Revenue in Gynecology Drugs Business (2015-2020) 13.5.5 Merck Recent Development 13.6 Abbott Laboratories 13.6.1 Abbott Laboratories Company Details 13.6.2 Abbott Laboratories Business Overview and Its Total Revenue 13.6.3 Abbott Laboratories Gynecology Drugs Introduction 13.6.4 Abbott Laboratories Revenue in Gynecology Drugs Business (2015-2020) 13.6.5 Abbott Laboratories Recent Development 13.7 GlaxoSmithKline 13.7.1 GlaxoSmithKline Company Details 13.7.2 GlaxoSmithKline Business Overview and Its Total Revenue 13.7.3 GlaxoSmithKline Gynecology Drugs Introduction 13.7.4 GlaxoSmithKline Revenue in Gynecology Drugs Business (2015-2020) 13.7.5 GlaxoSmithKline Recent Development 13.8 Johnson & Johnson 13.8.1 Johnson & Johnson Company Details 13.8.2 Johnson & Johnson Business Overview and Its Total Revenue 13.8.3 Johnson & Johnson Gynecology Drugs Introduction 13.8.4 Johnson & Johnson Revenue in Gynecology Drugs Business (2015-2020) 13.8.5 Johnson & Johnson Recent Development 13.9 Sanofi 13.9.1 Sanofi Company Details 13.9.2 Sanofi Business Overview and Its Total Revenue 13.9.3 Sanofi Gynecology Drugs Introduction 13.9.4 Sanofi Revenue in Gynecology Drugs Business (2015-2020) 13.9.5 Sanofi Recent Development 13.10 Novartis 13.10.1 Novartis Company Details 13.10.2 Novartis Business Overview and Its Total Revenue 13.10.3 Novartis Gynecology Drugs Introduction 13.10.4 Novartis Revenue in Gynecology Drugs Business (2015-2020) 13.10.5 Novartis Recent Development 13.11 Eli Lilly 10.11.1 Eli Lilly Company Details 10.11.2 Eli Lilly Business Overview and Its Total Revenue 10.11.3 Eli Lilly Gynecology Drugs Introduction 10.11.4 Eli Lilly Revenue in Gynecology Drugs Business (2015-2020) 10.11.5 Eli Lilly Recent Development 13.12 AstraZeneca 10.12.1 AstraZeneca Company Details 10.12.2 AstraZeneca Business Overview and Its Total Revenue 10.12.3 AstraZeneca Gynecology Drugs Introduction 10.12.4 AstraZeneca Revenue in Gynecology Drugs Business (2015-2020) 10.12.5 AstraZeneca Recent Development 13.13 Allergan 10.13.1 Allergan Company Details 10.13.2 Allergan Business Overview and Its Total Revenue 10.13.3 Allergan Gynecology Drugs Introduction 10.13.4 Allergan Revenue in Gynecology Drugs Business (2015-2020) 10.13.5 Allergan Recent Development 13.14 Amgen 10.14.1 Amgen Company Details 10.14.2 Amgen Business Overview and Its Total Revenue 10.14.3 Amgen Gynecology Drugs Introduction 10.14.4 Amgen Revenue in Gynecology Drugs Business (2015-2020) 10.14.5 Amgen Recent Development 13.15 Chengdu Enwei Group 10.15.1 Chengdu Enwei Group Company Details 10.15.2 Chengdu Enwei Group Business Overview and Its Total Revenue 10.15.3 Chengdu Enwei Group Gynecology Drugs Introduction 10.15.4 Chengdu Enwei Group Revenue in Gynecology Drugs Business (2015-2020) 10.15.5 Chengdu Enwei Group Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Gynecology Drugs Key Market Segments Table 2. Key Players Covered: Ranking by Gynecology Drugs Revenue Table 3. Ranking of Global Top Gynecology Drugs Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Gynecology Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Hormonal Therapy Table 6. Key Players of Non-hormonal Therapy Table 7. COVID-19 Impact Global Market: (Four Gynecology Drugs Market Size Forecast Scenarios) Table 8. Opportunities and Trends for Gynecology Drugs Players in the COVID-19 Landscape Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis Table 10. Key Regions/Countries Measures against Covid-19 Impact Table 11. Proposal for Gynecology Drugs Players to Combat Covid-19 Impact Table 12. Global Gynecology Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 13. Global Gynecology Drugs Market Size by Regions (US$ Million): 2020 VS 2026 Table 14. Global Gynecology Drugs Market Size by Regions (2015-2020) (US$ Million) Table 15. Global Gynecology Drugs Market Share by Regions (2015-2020) Table 16. Global Gynecology Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 17. Global Gynecology Drugs Market Share by Regions (2021-2026) Table 18. Market Top Trends Table 19. Key Drivers: Impact Analysis Table 20. Key Challenges Table 21. Gynecology Drugs Market Growth Strategy Table 22. Main Points Interviewed from Key Gynecology Drugs Players Table 23. Global Gynecology Drugs Revenue by Players (2015-2020) (Million US$) Table 24. Global Gynecology Drugs Market Share by Players (2015-2020) Table 25. Global Top Gynecology Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gynecology Drugs as of 2019) Table 26. Global Gynecology Drugs by Players Market Concentration Ratio (CR5 and HHI) Table 27. Key Players Headquarters and Area Served Table 28. Key Players Gynecology Drugs Product Solution and Service Table 29. Date of Enter into Gynecology Drugs Market Table 30. Mergers & Acquisitions, Expansion Plans Table 31. Global Gynecology Drugs Market Size by Type (2015-2020) (Million US$) Table 32. Global Gynecology Drugs Market Size Share by Type (2015-2020) Table 33. Global Gynecology Drugs Revenue Market Share by Type (2021-2026) Table 34. Global Gynecology Drugs Market Size Share by Application (2015-2020) Table 35. Global Gynecology Drugs Market Size by Application (2015-2020) (Million US$) Table 36. Global Gynecology Drugs Market Size Share by Application (2021-2026) Table 37. North America Key Players Gynecology Drugs Revenue (2019-2020) (Million US$) Table 38. North America Key Players Gynecology Drugs Market Share (2019-2020) Table 39. North America Gynecology Drugs Market Size by Type (2015-2020) (Million US$) Table 40. North America Gynecology Drugs Market Share by Type (2015-2020) Table 41. North America Gynecology Drugs Market Size by Application (2015-2020) (Million US$) Table 42. North America Gynecology Drugs Market Share by Application (2015-2020) Table 43. Europe Key Players Gynecology Drugs Revenue (2019-2020) (Million US$) Table 44. Europe Key Players Gynecology Drugs Market Share (2019-2020) Table 45. Europe Gynecology Drugs Market Size by Type (2015-2020) (Million US$) Table 46. Europe Gynecology Drugs Market Share by Type (2015-2020) Table 47. Europe Gynecology Drugs Market Size by Application (2015-2020) (Million US$) Table 48. Europe Gynecology Drugs Market Share by Application (2015-2020) Table 49. China Key Players Gynecology Drugs Revenue (2019-2020) (Million US$) Table 50. China Key Players Gynecology Drugs Market Share (2019-2020) Table 51. China Gynecology Drugs Market Size by Type (2015-2020) (Million US$) Table 52. China Gynecology Drugs Market Share by Type (2015-2020) Table 53. China Gynecology Drugs Market Size by Application (2015-2020) (Million US$) Table 54. China Gynecology Drugs Market Share by Application (2015-2020) Table 55. Japan Key Players Gynecology Drugs Revenue (2019-2020) (Million US$) Table 56. Japan Key Players Gynecology Drugs Market Share (2019-2020) Table 57. Japan Gynecology Drugs Market Size by Type (2015-2020) (Million US$) Table 58. Japan Gynecology Drugs Market Share by Type (2015-2020) Table 59. Japan Gynecology Drugs Market Size by Application (2015-2020) (Million US$) Table 60. Japan Gynecology Drugs Market Share by Application (2015-2020) Table 61. Southeast Asia Key Players Gynecology Drugs Revenue (2019-2020) (Million US$) Table 62. Southeast Asia Key Players Gynecology Drugs Market Share (2019-2020) Table 63. Southeast Asia Gynecology Drugs Market Size by Type (2015-2020) (Million US$) Table 64. Southeast Asia Gynecology Drugs Market Share by Type (2015-2020) Table 65. Southeast Asia Gynecology Drugs Market Size by Application (2015-2020) (Million US$) Table 66. Southeast Asia Gynecology Drugs Market Share by Application (2015-2020) Table 67. India Key Players Gynecology Drugs Revenue (2019-2020) (Million US$) Table 68. India Key Players Gynecology Drugs Market Share (2019-2020) Table 69. India Gynecology Drugs Market Size by Type (2015-2020) (Million US$) Table 70. India Gynecology Drugs Market Share by Type (2015-2020) Table 71. India Gynecology Drugs Market Size by Application (2015-2020) (Million US$) Table 72. India Gynecology Drugs Market Share by Application (2015-2020) Table 73. Central & South America Key Players Gynecology Drugs Revenue (2019-2020) (Million US$) Table 74. Central & South America Key Players Gynecology Drugs Market Share (2019-2020) Table 75. Central & South America Gynecology Drugs Market Size by Type (2015-2020) (Million US$) Table 76. Central & South America Gynecology Drugs Market Share by Type (2015-2020) Table 77. Central & South America Gynecology Drugs Market Size by Application (2015-2020) (Million US$) Table 78. Central & South America Gynecology Drugs Market Share by Application (2015-2020) Table 79. Pfizer Company Details Table 80. Pfizer Business Overview Table 81. Pfizer Product Table 82. Pfizer Revenue in Gynecology Drugs Business (2015-2020) (Million US$) Table 83. Pfizer Recent Development Table 84. Roche Company Details Table 85. Roche Business Overview Table 86. Roche Product Table 87. Roche Revenue in Gynecology Drugs Business (2015-2020) (Million US$) Table 88. Roche Recent Development Table 89. AbbVie Company Details Table 90. AbbVie Business Overview Table 91. AbbVie Product Table 92. AbbVie Revenue in Gynecology Drugs Business (2015-2020) (Million US$) Table 93. AbbVie Recent Development Table 94. Bayer Company Details Table 95. Bayer Business Overview Table 96. Bayer Product Table 97. Bayer Revenue in Gynecology Drugs Business (2015-2020) (Million US$) Table 98. Bayer Recent Development Table 99. Merck Company Details Table 100. Merck Business Overview Table 101. Merck Product Table 102. Merck Revenue in Gynecology Drugs Business (2015-2020) (Million US$) Table 103. Merck Recent Development Table 104. Abbott Laboratories Company Details Table 105. Abbott Laboratories Business Overview Table 106. Abbott Laboratories Product Table 107. Abbott Laboratories Revenue in Gynecology Drugs Business (2015-2020) (Million US$) Table 108. Abbott Laboratories Recent Development Table 109. GlaxoSmithKline Company Details Table 110. GlaxoSmithKline Business Overview Table 111. GlaxoSmithKline Product Table 112. GlaxoSmithKline Revenue in Gynecology Drugs Business (2015-2020) (Million US$) Table 113. GlaxoSmithKline Recent Development Table 114. Johnson & Johnson Business Overview Table 115. Johnson & Johnson Product Table 116. Johnson & Johnson Company Details Table 117. Johnson & Johnson Revenue in Gynecology Drugs Business (2015-2020) (Million US$) Table 118. Johnson & Johnson Recent Development Table 119. Sanofi Company Details Table 120. Sanofi Business Overview Table 121. Sanofi Product Table 122. Sanofi Revenue in Gynecology Drugs Business (2015-2020) (Million US$) Table 123. Sanofi Recent Development Table 124. Novartis Company Details Table 125. Novartis Business Overview Table 126. Novartis Product Table 127. Novartis Revenue in Gynecology Drugs Business (2015-2020) (Million US$) Table 128. Novartis Recent Development Table 129. Eli Lilly Company Details Table 130. Eli Lilly Business Overview Table 131. Eli Lilly Product Table 132. Eli Lilly Revenue in Gynecology Drugs Business (2015-2020) (Million US$) Table 133. Eli Lilly Recent Development Table 134. AstraZeneca Company Details Table 135. AstraZeneca Business Overview Table 136. AstraZeneca Product Table 137. AstraZeneca Revenue in Gynecology Drugs Business (2015-2020) (Million US$) Table 138. AstraZeneca Recent Development Table 139. Allergan Company Details Table 140. Allergan Business Overview Table 141. Allergan Product Table 142. Allergan Revenue in Gynecology Drugs Business (2015-2020) (Million US$) Table 143. Allergan Recent Development Table 144. Amgen Company Details Table 145. Amgen Business Overview Table 146. Amgen Product Table 147. Amgen Revenue in Gynecology Drugs Business (2015-2020) (Million US$) Table 148. Amgen Recent Development Table 149. Chengdu Enwei Group Company Details Table 150. Chengdu Enwei Group Business Overview Table 151. Chengdu Enwei Group Product Table 152. Chengdu Enwei Group Revenue in Gynecology Drugs Business (2015-2020) (Million US$) Table 153. Chengdu Enwei Group Recent Development Table 154. Research Programs/Design for This Report Table 155. Key Data Information from Secondary Sources Table 156. Key Data Information from Primary Sources List of Figures Figure 1. Global Gynecology Drugs Market Share by Type: 2020 VS 2026 Figure 2. Hormonal Therapy Features Figure 3. Non-hormonal Therapy Features Figure 4. Global Gynecology Drugs Market Share by Application: 2020 VS 2026 Figure 5. Hospital Pharmacies Case Studies Figure 6. Retail Pharmacies Case Studies Figure 7. Online Pharmacies Case Studies Figure 8. Gynecology Drugs Report Years Considered Figure 9. Global Gynecology Drugs Market Size YoY Growth 2015-2026 (US$ Million) Figure 10. Global Gynecology Drugs Market Share by Regions: 2020 VS 2026 Figure 11. Global Gynecology Drugs Market Share by Regions (2021-2026) Figure 12. Porter's Five Forces Analysis Figure 13. Global Gynecology Drugs Market Share by Players in 2019 Figure 14. Global Top Gynecology Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gynecology Drugs as of 2019 Figure 15. The Top 10 and 5 Players Market Share by Gynecology Drugs Revenue in 2019 Figure 16. North America Gynecology Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 17. Europe Gynecology Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 18. China Gynecology Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Japan Gynecology Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Southeast Asia Gynecology Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 21. India Gynecology Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Central & South America Gynecology Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 24. Pfizer Revenue Growth Rate in Gynecology Drugs Business (2015-2020) Figure 25. Roche Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. Roche Revenue Growth Rate in Gynecology Drugs Business (2015-2020) Figure 27. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. AbbVie Revenue Growth Rate in Gynecology Drugs Business (2015-2020) Figure 29. Bayer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. Bayer Revenue Growth Rate in Gynecology Drugs Business (2015-2020) Figure 31. Merck Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. Merck Revenue Growth Rate in Gynecology Drugs Business (2015-2020) Figure 33. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. Abbott Laboratories Revenue Growth Rate in Gynecology Drugs Business (2015-2020) Figure 35. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. GlaxoSmithKline Revenue Growth Rate in Gynecology Drugs Business (2015-2020) Figure 37. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018 Figure 38. Johnson & Johnson Revenue Growth Rate in Gynecology Drugs Business (2015-2020) Figure 39. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018 Figure 40. Sanofi Revenue Growth Rate in Gynecology Drugs Business (2015-2020) Figure 41. Novartis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 42. Novartis Revenue Growth Rate in Gynecology Drugs Business (2015-2020) Figure 43. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018 Figure 44. Eli Lilly Revenue Growth Rate in Gynecology Drugs Business (2015-2020) Figure 45. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018 Figure 46. AstraZeneca Revenue Growth Rate in Gynecology Drugs Business (2015-2020) Figure 47. Allergan Total Revenue (US$ Million): 2019 Compared with 2018 Figure 48. Allergan Revenue Growth Rate in Gynecology Drugs Business (2015-2020) Figure 49. Amgen Total Revenue (US$ Million): 2019 Compared with 2018 Figure 50. Amgen Revenue Growth Rate in Gynecology Drugs Business (2015-2020) Figure 51. Chengdu Enwei Group Total Revenue (US$ Million): 2019 Compared with 2018 Figure 52. Chengdu Enwei Group Revenue Growth Rate in Gynecology Drugs Business (2015-2020) Figure 53. Bottom-up and Top-down Approaches for This Report Figure 54. Data Triangulation Figure 55. Key Executives Interviewed

Pfizer Roche AbbVie Bayer Merck Abbott Laboratories GlaxoSmithKline Johnson & Johnson Sanofi Novartis Eli Lilly AstraZeneca Allergan Amgen Chengdu Enwei Group